Four things to know:
1. The executives, including Pharmaceutical Research and Manufacturers of America CEO Steve Ubl, used the July 24 meeting to voice opposition to the recently unveiled Senate bill to lower drug prices. PhRMA was joined by representatives from Pfizer and Amgen.
The executives don’t like the Senate bill’s price controls in Medicare Part D or the absence of “immediate and meaningful savings for patients at the pharmacy counter,” they told the president, according to Politico
2. House Minority Leader Kevin McCarthy, R-Calif., Rep. Mark Meadows R-N.C., and HHS Secretary Alex Azar were also at the meeting.
3. “At leader McCarthy’s request, the president hosted a meeting with PhRMA,” the White House told The Hill. “The president does not intend to negotiate with PhRMA, but listened respectfully.”
4. The Trump administration has made lowering drug prices a priority. It has released several proposals, and President Trump is considering an executive order.
Read the full report here.
More articles on pharmacy:
9 recent drug, device recalls
Owens Healthcare to sell 12 retail pharmacies to CVS
The pharmacies that received the most opioids in every state
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.